Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 52, n° 3S
page P7 (mars 2005)
Doi : 10.1016/j.jaad.2004.10.040
One-day high-dose valacyclovir reduces the quantity and duration of herpes simplex virus-1 (HSV-1) shedding after recurrent herpes labialis

Stan Gilbert, MD, University of Washington, Department of Medicine, Division of Dermatology and Dermatology and Laser Center, N.W., Bellingham, WA, United States

Dr. Gilbert is a member of the Valtrex Speakers Bureau for GSK and has been a consultant to Novartis Pharmaceuticals.
Research supported 50% by Glaxo Smith Kline, printing costs covered by GSK.

Top of the page

© 2005  American Academy of Dermatology, Inc.@@#104156@@